 |
Previous Article | Next Article 
Volume 17, Number 22,
Issue of November 15, 1997
pp. 8828-8841
The Olivocerebellar Projection Mediates Ibogaine-Induced
Degeneration of Purkinje Cells: A Model of Indirect, Trans-Synaptic
Excitotoxicity
Received April 30, 1997; revised Sept. 3, 1997; accepted Sept. 8, 1997.
Elizabeth O'Hearn and
Mark E. Molliver
Departments of Neuroscience and Neurology, The Johns Hopkins
University School of Medicine, Baltimore, Maryland 21205
Ibogaine, an indole alkaloid that causes hallucinations,
tremor, and ataxia, produces cerebellar neurotoxicity in rats,
manifested by degeneration of Purkinje cells aligned in narrow
parasagittal bands that are coextensive with activated glial cells.
Harmaline, a closely related alkaloid that excites inferior olivary
neurons, causes the same pattern of Purkinje cell degeneration,
providing a clue to the mechanism of toxicity. We have proposed that
ibogaine, like harmaline, excites neurons in the inferior olive,
leading to sustained release of glutamate at climbing fiber synapses on Purkinje cells. The objective of this study was to test the hypothesis that increased climbing fiber activity induced by ibogaine mediates excitotoxic Purkinje cell degeneration. The inferior olive was pharmacologically ablated in rats by a neurotoxic drug regimen using
3-acetylpyridine, and cerebellar damage attributed to subsequent administration of ibogaine was analyzed using immunocytochemical markers for neurons and glial cells. The results show that ibogaine administered after inferior olive ablation produced little or no
Purkinje cell degeneration or glial activation. That a lesion of the
inferior olive almost completely prevents the neurotoxicity demonstrates that ibogaine is not directly toxic to Purkinje cells, but
that the toxicity is indirect and dependent on integrity of the
olivocerebellar projection. We postulate that ibogaine-induced activation of inferior olivary neurons leads to release of glutamate simultaneously at hundreds of climbing fiber terminals distributed widely over the surface of each Purkinje cell. The unique circuitry of
the olivocerebellar projection provides this system with maximum synaptic security, a feature that confers on Purkinje cells a high
degree of vulnerability to excitotoxic injury.
Key words:
ibogaine;
harmaline;
Purkinje cell;
cerebellum;
excitotoxicity;
climbing fiber;
inferior olivary nucleus;
microglia
This article has been cited by other articles:

|
 |

|
 |
 
R Maciulaitis, V Kontrimaviciute, F. Bressolle, and V Briedis
Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review
Human and Experimental Toxicology,
March 1, 2008;
27(3):
181 - 194.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Hovland Jr., R. B. Boyd, M. T. Butt, J. A. Engelhardt, M. S. Moxness, M. H. Ma, M. G. Emery, N. B. Ernst, R. P. Reed, J. R. Zeller, et al.
Reprint: Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys
Toxicol Pathol,
December 1, 2007;
35(7):
1013 - 1029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Louis, W. Zheng, X. Mao, and D. C. Shungu
Blood harmane is correlated with cerebellar metabolism in essential tremor: A pilot study
Neurology,
August 7, 2007;
69(6):
515 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Hovland Jr., R. B. Boyd, M. T. Butt, J. A. Engelhardt, M. S. Moxness, M. H. Ma, M. G. Emery, N. B. Ernst, R. P. Reed, J. R. Zeller, et al.
Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys
Toxicol Pathol,
August 1, 2007;
35(5):
676 - 692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-Y. He and D. Ron
Autoregulation of glial cell line-derived neurotrophic factor expression: implications for the long-lasting actions of the anti-addiction drug, Ibogaine
FASEB J,
November 1, 2006;
20(13):
2420 - 2422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kimura, M. Sugimori, and R. R. Llinas
Purkinje cell long-term depression is prevented by T-588, a neuroprotective compound that reduces cytosolic calcium release from intracellular stores
PNAS,
November 22, 2005;
102(47):
17160 - 17165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Harper, P. M. Macey, M. A. Woo, K. E. Macey, T. G. Keens, D. Gozal, and J. R. Alger
Hypercapnic Exposure in Congenital Central Hypoventilation Syndrome Reveals CNS Respiratory Control Mechanisms
J Neurophysiol,
March 1, 2005;
93(3):
1647 - 1658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-Y. He, N. N. H. McGough, A. Ravindranathan, J. Jeanblanc, M. L. Logrip, K. Phamluong, P. H. Janak, and D. Ron
Glial Cell Line-Derived Neurotrophic Factor Mediates the Desirable Actions of the Anti-Addiction Drug Ibogaine against Alcohol Consumption
J. Neurosci.,
January 19, 2005;
25(3):
619 - 628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Woo, P. M. Macey, G. C. Fonarow, M. A. Hamilton, and R. M. Harper
Regional brain gray matter loss in heart failure
J Appl Physiol,
August 1, 2003;
95(2):
677 - 684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Weber, C. I. De Zeeuw, D. J. Linden, and C. Hansel
Long-term depression of climbing fiber-evoked calcium transients in Purkinje cell dendrites
PNAS,
March 4, 2003;
100(5):
2878 - 2883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Macey, L. A. Henderson, K. E. Macey, J. R. Alger, R. C. Frysinger, M. A. Woo, R. K. Harper, F. L. Yan-Go, and R. M. Harper
Brain Morphology Associated with Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med.,
November 15, 2002;
166(10):
1382 - 1387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Marcoli, C. Rosu, A. Bonfanti, M. Raiteri, and G. Maura
Inhibitory Presynaptic 5-Hydroxytryptamine2A Receptors Regulate Evoked Glutamate Release from Rat Cerebellar Mossy Fibers
J. Pharmacol. Exp. Ther.,
December 1, 2001;
299(3):
1106 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Patel and C. J. Hillard
Cannabinoid CB1 Receptor Agonists Produce Cerebellar Dysfunction in Mice
J. Pharmacol. Exp. Ther.,
April 12, 2001;
297(2):
629 - 637.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. J. Elble
Essential tremor frequency decreases with time
Neurology,
November 28, 2000;
55(10):
1547 - 1551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xu, L. W. Chang, W. Slikker Jr., S. F. Ali, R. L. Rountree, and A. C. Scallet
A Dose-Response Study of Ibogaine-Induced Neuropathology in the Rat Cerebellum
Toxicol. Sci.,
September 1, 2000;
57(1):
95 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|